Low Threshold Buprenorphine Induction at Harm Reduction Centers Grant Program

The Low Threshold Buprenorphine Induction at Harm Reduction Centers Grant Program, managed by the New Jersey Department of Health, aims to combat the opioid crisis by expanding access to medication-assisted treatment (MAT). This initiative seeks to reduce unmet treatment needs and opioid overdose deaths through comprehensive prevention, treatment, and recovery services. By collaborating with local stakeholders, the program targets high-burden communities, fostering healthier living and improving quality of life for New Jersey residents.

New Jersey Department of Health (NJDOH)
The New Jersey Department of Health leads the state’s response to public health challenges and works to improve health outcomes for all New Jersey residents. Through its three primary branches—Public Health Services, Health Systems, and Integrated Health—the Department collaborates across programs and partners to strengthen New Jersey’s health system. Guided by its mission to protect public health, promote healthy communities, and improve the quality of health care, the Department supports initiatives that advance prevention, system integration, and equitable access to health services statewide.
Low Threshold Buprenorphine Induction at Harm Reduction Centers Grant Program
To support the State Opioid Response (SOR) by conducting Low Threshold Buprenorphine Induction at Harm Reduction Centers (HRCs) that provide access to medication-assisted treatment (MAT), reduce unmet treatment need, and reducing opioid overdose related deaths through the provision of prevention, treatment and recovery activities for opioid use disorder.